Efficacy of the Preoperative Albumin–Bilirubin Grade for Predicting Survival and Outcomes of Postoperative Chemotherapy for Advanced Gastric Cancer

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Shen L, Shan Y-S, Hu H-M, et al. Management of gastric cancer in Asia: resource-stratified guidelines. Lancet Oncol. 2013;14(12):e535–e547. doi:10.1016/S1470-2045(13)70436-424176572
   PubMed Web of Science ®Google Scholar
• Kamangar F, Dores G, Anderson W. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J clin oncol. 2006;24(14):2137–2150. doi:10.1200/JCO.2005.05.230816682732
   PubMed Web of Science ®Google Scholar
• f0001gProgress in the treatment of advanced gastric cancer. Tumour Biol. 2017;39(7):1010428317714626.28671042
   PubMedGoogle Scholar
• Takama T, Okano K, Kondo A, et al. Predictors of postoperative complications in elderly and oldest old patients with gastric cancer. Gastric Cancer. 2015;18(3):653–661. doi:10.1007/s10120-014-0387-624874161
   PubMed Web of Science ®Google Scholar
• Xu J, Chen X, Wang X, et al. Preoperative hyponatremia and hypocalcemia predict poor prognosis in elderly gastric cancer patients. Cancer Manag Res. 2019;11:8765–8780.31632136
   PubMed Web of Science ®Google Scholar
• SL W, CL Z, DD H, et al. Sarcopenia adversely impacts postoperative clinical outcomes following gastrectomy in patients with gastric cancer: a prospective study. Ann Surg Oncol. 2016;23(2):556–564. doi:10.1245/s10434-015-4887-326668085
   PubMed Web of Science ®Google Scholar
• PJ J. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J clin oncol. 2015;33(6):550–558. doi:10.1200/JCO.2014.57.915125512453
   PubMed Web of Science ®Google Scholar
• YY W, JH Z, ZY S, et al. Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma. Br J Surg. 2016;103(6):725–734. doi:10.1002/bjs.1009527005482
   PubMed Web of Science ®Google Scholar
• Ma XL, Zhou JY, Gao XH, et al. Application of the albumin-bilirubin grade for predicting prognosis after curative resection of patients with early-stage hepatocellular carcinoma. Clin Chim Acta. 2016;462:15–22.27520748
   PubMed Web of Science ®Google Scholar
• Kanda M, Mizuno A, Tanaka C, et al. Nutritional predictors for postoperative short-term and long-term outcomes of patients with gastric cancer. Medicine. 2016;95(24):e3781. doi:10.1097/MD.000000000000378127310954
   PubMed Web of Science ®Google Scholar
• Jiang N, Deng J, Ding X, et al. Prognostic nutritional index predicts postoperative complications and long-term outcomes of gastric cancer. World J Gastroenterol. 2014;20(30):10537–10544. doi:10.3748/wjg.v20.i30.1053725132773
   PubMed Web of Science ®Google Scholar
• Ramadori G, Cameron S. Effects of systemic chemotherapy on the liver. Ann Hepatol. 2010;9(2):133–143. doi:10.1016/S1665-2681(19)31651-520526005
   PubMed Web of Science ®Google Scholar
• Kanda M, Tanaka C, Kobayashi D, et al. Preoperative albumin-bilirubin grade predicts recurrences after radical gastrectomy in patients with pt2-4 gastric cancer. World J Surg. 2018;42(3):773–781. doi:10.1007/s00268-017-4234-x28920160
   PubMed Web of Science ®Google Scholar
• Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017;20(1):1–19.
   Web of Science ®Google Scholar
• Kanda M, Murotani K, Kobayashi D, et al. Postoperative adjuvant chemotherapy with S-1 alters recurrence patterns and prognostic factors among patients with stage II/III gastric cancer: A propensity score matching analysis. Surgery. 2015;158(6):1573–1580. doi:10.1016/j.surg.2015.05.01726120068
   PubMed Web of Science ®Google Scholar
• Sasako M, Sakuramoto S, Katai H, et al. Five-year outcomes of a randomized Phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J clin oncol. 2011;29(33):4387–4393. doi:10.1200/JCO.2011.36.590822010012
   PubMed Web of Science ®Google Scholar
• Kondrup J, Rasmussen HH, Hamberg O, Stanga Z. Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clinical Nutrition. 2003;22(3):321–336. doi:10.1016/S0261-5614(02)00214-512765673
   PubMed Web of Science ®Google Scholar
• Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187–196. doi:10.1097/SLA.0b013e3181b13ca219638912
   PubMed Web of Science ®Google Scholar
• RL C, D-F M, DL R. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clinical Cancer Research. 2004;10(21):7252–7259. doi:10.1158/1078-0432.CCR-04-071315534099
   PubMed Web of Science ®Google Scholar
• DJ P. The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma. J Hepatol. 2017;66(2):338–346. doi:10.1016/j.jhep.2016.09.00827677714
   PubMed Web of Science ®Google Scholar
• Ma X, Zhou J, Gao X, et al. Application of the albumin-bilirubin grade for predicting prognosis after curative resection of patients with early-stage hepatocellular carcinoma. Clin Chim Acta. 2016;462:15–22. doi:10.1016/j.cca.2016.08.00527520748
   PubMed Web of Science ®Google Scholar
• Andreatos N, Amini N, Gani F, et al. Albumin-bilirubin score: predicting short-term outcomes including bile leak and post-hepatectomy liver failure following hepatic resection. J Gastrointestinal Surgery. 2017;21(2):238–248. doi:10.1007/s11605-016-3246-4
   PubMed Web of Science ®Google Scholar
• Hennessey D, Burke J, Ni-Dhonochu T, Shields C, Winter D, Mealy K. Preoperative hypoalbuminemia is an independent risk factor for the development of surgical site infection following gastrointestinal surgery: a multi-institutional study. Ann Surg. 2010;252(2):325–329. doi:10.1097/SLA.0b013e3181e9819a20647925
   PubMed Web of Science ®Google Scholar
• Ryan A, Reynolds J, Healy L, et al. Enteral nutrition enriched with eicosapentaenoic acid (EPA) preserves lean body mass following esophageal cancer surgery: results of a double-blinded randomized controlled trial. Ann Surg. 2009;249(3):355–363. doi:10.1097/SLA.0b013e31819a478919247018
   PubMed Web of Science ®Google Scholar
• Song G, Tian X, Liang H, et al. Role of enteral immunonutrition in patients undergoing surgery for gastric cancer: a systematic review and meta-analysis of randomized controlled trials. Medicine. 2015;94(31):e1311. doi:10.1097/MD.000000000000131126252314
   PubMed Web of Science ®Google Scholar
• Rodríguez L, Cervantes E, Ortiz R. Malnutrition and gastrointestinal and respiratory infections in children: a public health problem. Int J Environ Res Public Health. 2011;8(4):1174–1205. doi:10.3390/ijerph804117421695035
   PubMed Web of Science ®Google Scholar
• Pelletier DL, Frongillo EA Jr, Habicht JP. Epidemiologic evidence for a potentiating effect of malnutrition on child mortality. Am J Public Health. 1993;83(8):1130–1133. doi:10.2105/AJPH.83.8.11308342721
   PubMed Web of Science ®Google Scholar
• Rodríguez L, González C, Flores L, Jiménez-Zamudio L, Graniel J, Ortiz R. Assessment by flow cytometry of cytokine production in malnourished children. Clin Diagn Lab Immunol. 2005;12(4):502–507. doi:10.1128/CDLI.12.4.502-507.200515817757
   PubMedGoogle Scholar
• González-Torres C, González-Martínez H, Miliar A, et al. Effect of malnutrition on the expression of cytokines involved in Th1 cell differentiation. Nutrients. 2013;5(2):579–593. doi:10.3390/nu502057923429441
   PubMed Web of Science ®Google Scholar
• Migita K, Takayama T, Saeki K, et al. The prognostic nutritional index predicts long-term outcomes of gastric cancer patients independent of tumor stage. Ann Surg Oncol. 2013;20(8):2647–2654. doi:10.1245/s10434-013-2926-523463091
   PubMed Web of Science ®Google Scholar
• Thurnham D. Interactions between nutrition and immune function: using inflammation biomarkers to interpret micronutrient status. Proc Nutr Soc. 2014;73(1):1–8. doi:10.1017/S002966511300366224169363
   PubMed Web of Science ®Google Scholar
• Kanda M, Kodera Y, Sakamoto J. Updated evidence on adjuvant treatments for gastric cancer. Expert Rev Gastroenterol Hepatol. 2015;9(12):1549–1560. doi:10.1586/17474124.2015.109437326414453
   PubMed Web of Science ®Google Scholar
• Noh S, Park S, Yang H, et al. Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised Phase 3 trial. Lancet Oncol. 2014;15(12):1389–1396. doi:10.1016/S1470-2045(14)70473-525439693
   PubMed Web of Science ®Google Scholar
• Iizuka A, Kanda M, Ito S, et al. Proposal of a scoring scale to estimate risk of the discontinuation of s-1 adjuvant monotherapy in patients with stage ii to iii gastric cancer: a multi-institutional dataset analysis. World J Surg. 2019;43(8):2016–2024. doi:10.1007/s00268-019-04942-y30737551
   PubMed Web of Science ®Google Scholar